Elivity, a new longevity supplement brand, has made its debut in Singapore and it aims to move Asia’s understanding of the category beyond the use of nicotinamide mononucleotide (NMN).
The testing of 18 commercially available NMN (nicotinamide mononucleotide) supplements sold in Singapore found that most products did not meet label claims, and researchers have called for industry-wide effort in resolving the issue.